The change would cap the maximum "indirect cost rate" research institutions charge the government at 15% of any given grant.

Readers are urged to read the risk factors set forth in the Company’s filings with the United States Securities and Exchange Commission at https://www.sec.gov. The Company disclaims any intention or ...

Lixte Biotechnology (LIXT) announced that it has filed a request for withdrawal with the SEC of the company’s Registration Statement on Form ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Partners Ali Razai, Benjamin Anger, Brandon Smith and Benjamin Everton joined Morgan Lewis’ Orange County office, while ...

Springworks, which listed its shares in New York in 2019, is a commercial-stage biotech firm that develops drugs to treat various forms of cancer and other rare diseases such as uterine cancer and ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

The "Crown" logo, PanOxyl and Blue Lizard are registered trademarks of Crown Laboratories, Inc. SkinPen and StriVectin are registered trademarks of Bellus Medical, LLC and StriVectin Operating Company ...

The Dovetail Certified Service Provider program sets stringent standards of proficiency and data quality that service labs ...

Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an AI-powered drug discovery startup, Manas AI.